New lung implant aims to ease breathing for emphysema patients
NCT ID NCT05854550
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new implant designed to release trapped air in the lungs of people with severe emphysema or COPD. Up to 48 participants received up to two procedures to place the implants. Researchers checked if the device was safe and if it improved breathing over 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMPHYSEMA OR COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Macquarie University Hospital
Macquarie, New South Wales, 2109, Australia
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New exercise trick boosts strength in lung disease patients
- Can a heart drug combo help COPD lungs?
- Surgery-Plus-Valve combo aims to boost lung function in emphysema patients
- Surgical fix offers new hope for failed emphysema treatment
- New lung implant aims to release trapped air in emphysema patients
- Lung valve registry shows promise for emphysema patients